Posted by Michael Wonder on 03 Aug 2016
CADTH calls for patient input on submission from Allergan for Fetzima (levomilnacipran hydrochloride)
2 August 2016 - CADTH is calling for patient input on a pending submission from Allergan for Fetzima.
Health Canada approved Fetzima (levomilnacipran hydrochloride) on 8 May 205 for the short-term symptomatic relief of major depressive disorder.
The submission is due on 30 August 2016.
